MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.


Atrial fibrillation is a medical condition that causes an irregular heart beat. It affects 33 million people worldwide.
Unfortunately gold standard surgical ablation treatments are associated with failure rate of up to 30%. The result: recurrent AFib and repeat ablation procedures.
Hyblate's system combines RF ablation and balloon catheters for accuracy, ease-of use & higher success rates.
Hyblate is led by CEO Liron Tayeb (previously Edwards) joined by Profs. Suleiman & Gepstein from Rambam
The Hyblate Catheter is designed to treat heart rhythm problems, increasing success rates over current methods that only reach 70%.

Connect with Hyblate



2019 Finalist Israel

Sub industry

Medical Devices


Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.